Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Lisata Therapeutics(LSTA) the EBIT is -3.992 M (+18%);the EPS is -0.322 (+40.59%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
EBIT
-0.00B18.00%
----
----
EPS
-0.321740.59%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf